Michael D Robbins

US Patent:

6552166, Apr 22, 2003

Filed:

Oct 18, 2000

Appl. No.:

09/691523

Inventors:

Joseph E. Lynch - Plainfield NJ
Michael A. Robbins - Short Hills NJ
David R. Lieberman - Jersey City NJ

Assignee:

Merck Co., Inc. - Rahway NJ

International Classification:

C07K 110

US Classification:

530322, 530338, 530345

Abstract:

The present invention is directed to the improved synthesis of compounds of formula I: which may be useful in the treatment of prostate cancer. Such compounds are synthesized in the presence of a carboxyl activating agent, an additive and a base for the preparation of a PSA conjugate which comprises an anthracycline antibiotic and an oligopeptide.

US Patent:

20030171991, Sep 11, 2003

Filed:

Jan 21, 2003

Appl. No.:

10/348092

Inventors:

Michael Robbins - San Diego CA, US

International Classification:

G06F017/60

US Classification:

705/014000

Abstract:

The present invention is a method and apparatus to insert unavoidable audiovisual advertisements for content providers such as radio station streamcasters. When a person clicks on content provider's website to receive free content, the user must first pass through an audiovisual advertisement. If the user attempts to evade the commercial by minimizing the browser or alt-tab, then the advertisement stops and the user returns to the previous page. Subsequent advertisements require the user to watch the entire commercial before continuing with requested content. Once the commercial(s) finish, the user can access content requested and minimize the browser or alt-tab without interrupting content request. By requiring users pass through a gateway commercial, and making the terms of watching the commercial more strict, the present invention creates high value, homogeneous advertising units.

US Patent:

20080285250, Nov 20, 2008

Filed:

May 15, 2007

Appl. No.:

11/749093

Inventors:

Andrew W. Kaliszek - Phoenix AZ, US
Derek T. Mead - Scottsdale AZ, US
Jason C. Grooms - St. Petersburg FL, US
Michael D. Robbins - Peoria AZ, US
Christopher S. Herman - Glendale AZ, US

Assignee:

Honeywell International, Inc. - Morristown NJ

International Classification:

H05K 7/00
H05K 13/04

US Classification:

361807, 29428, 361808

Abstract:

A structural packaging assembly to support a multi-function optic chip or the like is mountable in a gyroscopic unit. An example assembly includes a housing mounted to a mounting plate. The chip is located in the housing, which in turn is coupled to a mounting plate. The housing may have a prescribed section modulus capable of sufficiently withstanding applied vibrations within a predefined vibrational range, such as a vibrational range at or below about 3500 Hz. The structural packaging assembly utilizes a mounting system with mounting feet that clamp to dowels, which in turn have been press fit into the mounting plate. In one embodiment, the mounting feet take the form of “C” clamp mechanisms, which after being clamped to the dowels, allow for resonance dampening between the housing and the mounting plate.

US Patent:

20110161173, Jun 30, 2011

Filed:

Dec 28, 2010

Appl. No.:

12/979400

Inventors:

Michael Robbins - Bellevue WA, US

International Classification:

G06Q 30/00

US Classification:

705 1455, 705 1473, 705 1466

Abstract:

Methods and systems for providing advertising content online, through handheld devices or interactive digital television where the user selects the commercial desired from a list. The audiovisual advertisement is only served when the user selects the specific commercial to watch in order to gain free access to content or services.

US Patent:

63230410, Nov 27, 2001

Filed:

Jun 7, 1995

Appl. No.:

8/472600

Inventors:

Douglas A. Fisher - New York NY
Michael D. Robbins - New York NY

Assignee:

Pfizer Inc. - New York NY

International Classification:

G01N 33566
G01N 3353
C12Q 168
C12N 900

US Classification:

436501

Abstract:

This invention relates to novel nucleic acid sequences encoding three novel human phosphodiesterase (hPDE IV) isozymes. It also relates to polypeptides encoded by such sequences. This invention also relates to an assay method for detecting the presence of such novel isozymes in human cells, and to a method of identifying compounds or other substances that inhibit or modify the activity of such isozymes.